Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Web-Based Coping and Communication Skills Intervention for Women Who Are Newly Diagnosed With Gynecological Cancer: A Pilot Study

NCT03902379 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03902379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Web-Based Coping and Communication Skills Intervention for Women Who Are Newly Diagnosed With Gynecological Cancer: A Pilot Study
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Not applicable
Overall status
Withdrawn
Start date
July 27, 2016
Completion date
May 31, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial carcinoma, stage 0 fallopian tube cancer ajcc v7, stage i fallopian tube cancer ajcc v6 and v7, stage i ovarian cancer ajcc v6 and v7, stage ia fallopian tube cancer ajcc v6 and v7, stage ia ovarian cancer ajcc v6 and v7, stage ib fallopian tube cancer ajcc v6 and v7, stage ib ovarian cancer ajcc v6 and v7, stage ic fallopian tube cancer ajcc v6 and v7, stage ic ovarian cancer ajcc v6 and v7, stage ii cervical cancer ajcc v7, stage ii fallopian tube cancer ajcc v6 and v7, stage ii ovarian cancer ajcc v6 and v7, stage ii uterine corpus cancer ajcc v7, stage iia cervical cancer ajcc v7, stage iia fallopian tube cancer ajcc v6 and v7, stage iia ovarian cancer ajcc v6 and v7, stage iia1 cervical cancer ajcc v7, stage iia2 cervical cancer ajcc v7, stage iib cervical cancer ajcc v6 and v7, stage iib fallopian tube cancer ajcc v6 and v7, stage iib ovarian cancer ajcc v6 and v7, stage iic fallopian tube cancer ajcc v6 and v7, stage iic ovarian cancer ajcc v6 and v7, stage iii cervical cancer ajcc v6 and v7, stage iii fallopian tube cancer ajcc v7, stage iii ovarian cancer ajcc v6 and v7, stage iii primary peritoneal cancer ajcc v7, stage iii uterine corpus cancer ajcc v7, stage iiia cervical cancer ajcc v6 and v7, stage iiia fallopian tube cancer ajcc v7, stage iiia ovarian cancer ajcc v6 and v7, stage iiia primary peritoneal cancer ajcc v7, stage iiia uterine corpus cancer ajcc v7, stage iiib cervical cancer ajcc v6 and v7, stage iiib fallopian tube cancer ajcc v7, stage iiib ovarian cancer ajcc v6 and v7, stage iiib primary peritoneal cancer ajcc v7, stage iiib uterine corpus cancer ajcc v7, stage iiic fallopian tube cancer ajcc v7, stage iiic ovarian cancer ajcc v6 and v7, stage iiic primary peritoneal cancer ajcc v7, stage iiic uterine corpus cancer ajcc v7, stage iiic1 uterine corpus cancer ajcc v7, stage iiic2 uterine corpus cancer ajcc v7, stage iv cervical cancer ajcc v6 and v7, stage iv fallopian tube cancer ajcc v6 and v7, stage iv ovarian cancer ajcc v6 and v7, stage iv primary peritoneal cancer ajcc v7, stage iv uterine corpus cancer ajcc v7, stage iva cervical cancer ajcc v6 and v7, stage iva uterine corpus cancer ajcc v7, stage ivb cervical cancer ajcc v6 and v7, stage ivb uterine corpus cancer ajcc v7, uterine carcinosarcoma, uterine corpus sarcoma